
LINK . SPRINGER . COM {
}
Title:
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide | Journal of Neuro-Oncology
Description:
Epigenetic silencing of the O6-methylguanine-DNA-methyltransferase (MGMT) gene by promoter methylation is correlated with improved progression-free survival (PFS) and overall survival (OS) in adult patients with newly diagnosed glioblastoma multiforme (GBM) who receive alkylating agents. The aim of this study is to determine the correlation between MGMT and survival in elderly patients with GBM treated with radiotherapy (RT) and temozolomide (TMZ). Eighty-three patients aged 70 years or older with histologically confirmed GBM treated with RT plus TMZ between February 2005 and September 2009 were investigated in this study. The methylation status of the MGMT promoter was determined by polymerase chain reaction analysis. Median PFS and OS were 7.5 and 12.8 months, respectively. The MGMT promoter was methylated in 42 patients (50.6%) and unmethylated in 41 patients (49.4%). Median OS was 15.3 months in methylated patients and 10.2 months in unmethylated patients (P = 0.0001). Median PFS was 10.5 months in methylated tumors and 5.5 months in unmethylated tumors (P = 0.0001). On multivariate analysis MGMT methylation status emerged as the strongest independent prognostic factor for OS and PFS (P = 0.004 and P = 0.005, respectively). The results of the present study suggest that MGMT methylation status might be an important prognostic factor associated with better OS and PFS in elderly patients with GBM treated with RT and TMZ.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {đ}
- Education
- Science
- Non-Profit & Charity
Content Management System {đ}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of link.springer.com audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {đ¸}
We donât know how the website earns money.
Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {đ}
article, google, scholar, patients, glioblastoma, pubmed, cas, radiotherapy, elderly, temozolomide, mgmt, study, cancer, survival, methylation, oncol, multiforme, promoter, analysis, concomitant, adjuvant, minniti, malignant, neurooncol, treated, access, glioma, privacy, cookies, content, journal, correlation, gene, pfs, newly, diagnosed, status, months, prognostic, hospital, prognosis, engl, med, clin, treatment, department, italy, data, publish, research,
Topics {âď¸}
o6-alkylguanine-dna alkyltransferase analysis o6-methylguanine-dna methyltransferase o6-methylguanine-dna-methyltransferase month download article/chapter dna-repair gene mgmt mgmt methylation status improved progression-free survival dna mismatch repair cancer brain tumour full article pdf patients aged 70Â years privacy choices/manage cookies methylation status poor prognosis patients important prognostic factor tumor histological type mgmt gene silencing newly diagnosed glioblastoma supratentorial malignant glioma mgmt methylation neuro-oncology aims santâ andrea hospital phase ii study primary human neoplasia eortc-ncic trial promoter methylation phase ii studies present study suggest high grade glioma gamma knife radiosurgery los angeles county schold sc jr herman jg clinico-therapeutic remarks university âla sapienzaâ article minniti primary glioblastoma multiforme conditions privacy policy european economic area van der bent population-based description primary temozolomide chemotherapy article journal radiation oncology groups check access instant access accepting optional cookies receive alkylating agents national cancer institute journal finder publish
Schema {đşď¸}
WebPage:
mainEntity:
headline:Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide
description:Epigenetic silencing of the O6-methylguanine-DNA-methyltransferase (MGMT) gene by promoter methylation is correlated with improved progression-free survival (PFS) and overall survival (OS) in adult patients with newly diagnosed glioblastoma multiforme (GBM) who receive alkylating agents. The aim of this study is to determine the correlation between MGMT and survival in elderly patients with GBM treated with radiotherapy (RT) and temozolomide (TMZ). Eighty-three patients aged 70Â years or older with histologically confirmed GBM treated with RT plus TMZ between February 2005 and September 2009 were investigated in this study. The methylation status of the MGMT promoter was determined by polymerase chain reaction analysis. Median PFS and OS were 7.5 and 12.8Â months, respectively. The MGMT promoter was methylated in 42 patients (50.6%) and unmethylated in 41 patients (49.4%). Median OS was 15.3Â months in methylated patients and 10.2Â months in unmethylated patients (PÂ =Â 0.0001). Median PFS was 10.5Â months in methylated tumors and 5.5Â months in unmethylated tumors (PÂ =Â 0.0001). On multivariate analysis MGMT methylation status emerged as the strongest independent prognostic factor for OS and PFS (PÂ =Â 0.004 and PÂ =Â 0.005, respectively). The results of the present study suggest that MGMT methylation status might be an important prognostic factor associated with better OS and PFS in elderly patients with GBM treated with RT and TMZ.
datePublished:2010-08-05T00:00:00Z
dateModified:2010-08-05T00:00:00Z
pageStart:311
pageEnd:316
sameAs:https://doi.org/10.1007/s11060-010-0324-4
keywords:
Glioblastoma
Elderly
Radiotherapy
Temozolomide
MGMT
Oncology
Neurology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig3_HTML.gif
isPartOf:
name:Journal of Neuro-Oncology
issn:
1573-7373
0167-594X
volumeNumber:102
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Giuseppe Minniti
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Salvati
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:A. Arcella
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:F. Buttarelli
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:A. DâElia
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Neurosurgery, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:G. Lanzetta
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:V. Esposito
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:S. Scarpino
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:R. Maurizi Enrici
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:F. Giangaspero
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide
description:Epigenetic silencing of the O6-methylguanine-DNA-methyltransferase (MGMT) gene by promoter methylation is correlated with improved progression-free survival (PFS) and overall survival (OS) in adult patients with newly diagnosed glioblastoma multiforme (GBM) who receive alkylating agents. The aim of this study is to determine the correlation between MGMT and survival in elderly patients with GBM treated with radiotherapy (RT) and temozolomide (TMZ). Eighty-three patients aged 70Â years or older with histologically confirmed GBM treated with RT plus TMZ between February 2005 and September 2009 were investigated in this study. The methylation status of the MGMT promoter was determined by polymerase chain reaction analysis. Median PFS and OS were 7.5 and 12.8Â months, respectively. The MGMT promoter was methylated in 42 patients (50.6%) and unmethylated in 41 patients (49.4%). Median OS was 15.3Â months in methylated patients and 10.2Â months in unmethylated patients (PÂ =Â 0.0001). Median PFS was 10.5Â months in methylated tumors and 5.5Â months in unmethylated tumors (PÂ =Â 0.0001). On multivariate analysis MGMT methylation status emerged as the strongest independent prognostic factor for OS and PFS (PÂ =Â 0.004 and PÂ =Â 0.005, respectively). The results of the present study suggest that MGMT methylation status might be an important prognostic factor associated with better OS and PFS in elderly patients with GBM treated with RT and TMZ.
datePublished:2010-08-05T00:00:00Z
dateModified:2010-08-05T00:00:00Z
pageStart:311
pageEnd:316
sameAs:https://doi.org/10.1007/s11060-010-0324-4
keywords:
Glioblastoma
Elderly
Radiotherapy
Temozolomide
MGMT
Oncology
Neurology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-010-0324-4/MediaObjects/11060_2010_324_Fig3_HTML.gif
isPartOf:
name:Journal of Neuro-Oncology
issn:
1573-7373
0167-594X
volumeNumber:102
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Giuseppe Minniti
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M. Salvati
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:A. Arcella
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:F. Buttarelli
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:A. DâElia
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Neurosurgery, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:G. Lanzetta
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:V. Esposito
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
type:Person
name:S. Scarpino
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:R. Maurizi Enrici
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
name:F. Giangaspero
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Neuro-Oncology
issn:
1573-7373
0167-594X
volumeNumber:102
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Neurosurgery, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Giuseppe Minniti
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
email:[email protected]
name:M. Salvati
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:A. Arcella
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:F. Buttarelli
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:A. DâElia
affiliation:
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Neurosurgery, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:G. Lanzetta
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:V. Esposito
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:S. Scarpino
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:R. Maurizi Enrici
affiliation:
name:Santâ Andrea Hospital, University âLa Sapienzaâ
address:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
name:F. Giangaspero
affiliation:
name:Neuromed Institute
address:
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
type:PostalAddress
type:Organization
name:Umberto I Hospital, University âLa Sapienzaâ
address:
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
name:Department of Neurosurgery, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Pathology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
name:Department of Radiation Oncology, Santâ Andrea Hospital, University âLa Sapienzaâ, Rome, Italy
name:Department of Neurological Sciences, Neuromed Institute, Pozzilli (IS), Italy
name:Department of Pathology, Umberto I Hospital, University âLa Sapienzaâ, Rome, Italy
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {đ}(118)
- Revenue of https://www.springernature.com/gp/authors
- What's the financial gain of https://link.springernature.com/home/?
- What is the monthly revenue of https://order.springer.com/public/cart?
- Income figures for https://submission.nature.com/new-submission/11060/3
- What's the monthly income of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- How much does https://doi.org/10.1056%2FNEJMoa043330 bring in each month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15758009?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide%20for%20glioblastoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa043330&volume=352&pages=987-996&publication_year=2005&author=Stupp%2CR&author=Mason%2CW&author=Bent%2CM
- https://doi.org/10.1056%2FNEJM200011093431901's total income per month
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11070098
- How much profit is http://scholar.google.com/scholar_lookup?&title=Inactivation%20of%20the%20DNA-repair%20gene%20MGMT%20and%20the%20clinical%20response%20of%20gliomas%20to%20alkylating%20agents&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200011093431901&volume=343&pages=1350-1354&publication_year=2000&author=Esteller%2CM&author=Garcia-Foncillas%2CJ making per month?
- Get to know https://doi.org/10.1056%2FNEJMra023075's earnings
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14627790 is on a monthly basis
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Gene%20silencing%20in%20cancer%20in%20association%20with%20promoter%20hypermethylation&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra023075&volume=349&pages=2042-2054&publication_year=2003&author=Herman%2CJG&author=Baylin%2CSB?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9779706 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Correlation%20of%20tumor%20O6%20methylguanine-DNA%20methyltransferase%20levels%20with%20survival%20of%20malignant%20astrocytoma%20patients%20treated%20with%20bis-chloroethylnitrosourea%3A%20a%20Southwest%20Oncology%20Group%20Study&journal=J%20Clin%20Oncol&volume=16&pages=3310-3315&publication_year=1998&author=Jaeckle%2CKA&author=Eyre%2CHJ&author=Townsend%2CJJ makes per month
- What's the income generated by https://doi.org/10.1056%2FNEJMoa043331 each month?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15758010 make?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=MGMT%20gene%20silencing%20and%20benefit%20from%20temozolomide%20in%20glioblastoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa043331&volume=352&pages=997-1003&publication_year=2005&author=Hegi%2CME&author=Diserens%2CAC&author=Gorlia%2CT have monthly?
- What's the income of https://doi.org/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1195%3A%3AAID-CNCR19%3E3.0.CO%3B2-V?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9070498?
- http://scholar.google.com/scholar_lookup?&title=Descriptive%20epidemiology%20of%20cerebral%20gliomas%20in%20France&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1195%3A%3AAID-CNCR19%3E3.0.CO%3B2-V&volume=79&pages=1195-2202&publication_year=1997&author=Fleury%2CA&author=Menegoz%2CF&author=Grosclaude%2CP's revenue stream
- See how much https://doi.org/10.3171%2Fjns.1998.88.1.0001 makes per month
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9420066 earning monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Survival%20rates%20in%20patients%20with%20primary%20malignant%20brain%20tumors%20stratified%20by%20patient%20age%20and%20tumor%20histological%20type%3A%20an%20analysis%20based%20on%20Surveillance%2C%20Epidemiology%2C%20and%20End%20Results%20%28SEER%29%20data%2C%201973%E2%80%931991&journal=J%20Neurosurg&doi=10.3171%2Fjns.1998.88.1.0001&volume=88&pages=1-10&publication_year=1998&author=Davis%2CFG&author=Freels%2CS&author=Grutsch%2CJ&author=Barlas%2CS&author=Brem%2CS?
- What's https://doi.org/10.1002%2Fcncr.21539's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16288487 pull in monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20population-based%20description%20of%20glioblastoma%20multiforme%20in%20Los%20Angeles%20County%2C%201974%E2%80%931999&journal=Cancer&doi=10.1002%2Fcncr.21539&volume=104&pages=2798-2806&publication_year=2005&author=Chakrabarti%2CI&author=Cockburn%2CM&author=Cozen%2CW generate?
- How much profit does https://doi.org/10.1016%2F0360-3016%2894%2990573-8 make?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8040031?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=A%20prospective%20study%20of%20short%20course%20RT%20in%20poor%20prognosis%20glioblastoma%20multiforme&journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&doi=10.1016%2F0360-3016%2894%2990573-8&volume=29&pages=835-839&publication_year=1994&author=Bauman%2CGS&author=Fisher%2CBJ&author=Halperin%2CEC
- How much does https://doi.org/10.1016%2F0167-8140%2894%2990064-7 net monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7535939's total income per month
- Profit of http://scholar.google.com/scholar_lookup?&title=Hypofractionated%20radiotherapy%20as%20palliative%20treatment%20in%20poor%20prognosis%20patients%20with%20high%20grade%20glioma&journal=Radiother%20Oncol&doi=10.1016%2F0167-8140%2894%2990064-7&volume=33&pages=113-116&publication_year=1994&author=Thomas%2CR&author=James%2CN&author=Guerrero%2CD
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=A%20short%20fractionation%20radiotherapy%20treatment%20for%20poor%20prognosis%20patients%20with%20high%20grade%20glioma&journal=Clin%20Oncol%20%28R%20Coll%20Radiol%29&volume=9&pages=20-24&publication_year=1997&author=Ford%2CJM&author=Stenning%2CSP&author=Bootle%2CDJ?
- How profitable is https://doi.org/10.1023%2FA%3A1005750111883?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9195491
- Earnings of http://scholar.google.com/scholar_lookup?&title=A%20prospective%20study%20of%20short%20course%20radiotherapy%20in%20elderly%20patients%20with%20malignant%20glioma&journal=J%20Neurooncol&doi=10.1023%2FA%3A1005750111883&volume=33&pages=201-214&publication_year=1997&author=Hoegler%2CDB&author=Davey%2CP
- See how much https://doi.org/10.1016%2FS0167-8140%2803%2900077-X makes per month
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12812848
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Hypofractionated%20radiotherapy%20for%20poor%20prognosis%20malignant%20glioma%3A%20matched%20pair%20survival%20analysis%20with%20MRC%20controls&journal=Radiother%20Oncol&doi=10.1016%2FS0167-8140%2803%2900077-X&volume=67&pages=177-182&publication_year=2003&author=McAleese%2CJJ&author=Stenning%2CSP&author=Ashley%2CS?
- What's https://doi.org/10.1200%2FJCO.2004.06.082's gross income?
- http://scholar.google.com/scholar_lookup?&title=Abbreviated%20course%20of%20radiation%20therapy%20in%20older%20patients%20with%20glioblastoma%20multiforme%3A%20a%20prospective%20randomized%20clinical%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2004.06.082&volume=22&pages=1593-1598&publication_year=2004&author=Roa%2CW&author=Brasher%2CPMA&author=Bauman%2CG's total income per month
- How much profit is https://doi.org/10.1056%2FNEJMoa065901 making per month?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Radiotherapy%20for%20glioblastoma%20in%20the%20elderly&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa065901&volume=356&pages=1527-1535&publication_year=2007&author=Keime-Guiber%2CF&author=Chinot%2CO&author=Taillandier%2CL
- What's the financial gain of https://doi.org/10.1002%2Fcncr.11323?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12712481 makes per month
- How much money does http://scholar.google.com/scholar_lookup?&title=Temozolomide%20as%20an%20alternative%20to%20irradiation%20for%20elderly%20patients%20with%20newly%20diagnosed%20malignant%20gliomas&journal=Cancer&doi=10.1002%2Fcncr.11323&volume=97&pages=2262-2266&publication_year=2003&author=Glantz%2CM&author=Chamberlain%2CM&author=Liu%2CQ generate?
- Check the income stats for https://doi.org/10.1002%2Fcncr.20224
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15139066
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20temozolomide%20without%20radiotherapy%20in%20newly%20diagnosed%20glioblastoma%20multiforme%20in%20an%20elderly%20populations&journal=Cancer&doi=10.1002%2Fcncr.20224&volume=100&pages=2208-2214&publication_year=2004&author=Chinot%2COL&author=Barrie%2CM&author=Frauger%2CE?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17019532's gross income?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20pilot%20study%20of%20primary%20temozolomide%20chemotherapy%20and%20deferred%20radiotherapy%20in%20elderly%20patients%20with%20glioblastoma&journal=J%20Neurooncol&doi=10.1007%2Fs11060-006-9269-z&volume=82&pages=207-209&publication_year=2007&author=Chamberlain%2CMC&author=Chalmers%2CL?
- How much does https://doi.org/10.1002%2Fcncr.11097 rake in every month?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20prospective%20study%20in%20glioblastoma%20multiforme&journal=Cancer&doi=10.1002%2Fcncr.11097&volume=3&pages=657-662&publication_year=2003&author=Brandes%2CAA&author=Vastola%2CF&author=Basso%2CU generate?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Postoperative%20treatment%20of%20primary%20glioblastoma%20multiforme%20with%20radiation%20and%20concomitant%20temozolomide%20in%20elderly%20patients&journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&volume=15&issue=70&pages=987-992&publication_year=2008&author=Combs%2CSE&author=Wagner%2CJ&author=Bischof%2CM
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18250965's financial summary
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide%20for%20glioblastoma%20in%20elderly%20patients&journal=J%20Neurooncol&doi=10.1007%2Fs11060-008-9538-0&volume=88&pages=97-103&publication_year=2008&author=Minniti%2CG&author=Sanctis%2CV&author=Muni%2CR
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18758912 generate monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Hypofractionated%20radiotherapy%20followed%20by%20adjuvant%20chemotherapy%20with%20temozolomide%20in%20elderly%20patients%20with%20glioblastoma&journal=J%20Neurooncol&doi=10.1007%2Fs11060-008-9689-z&volume=91&pages=95-100&publication_year=2009&author=Minniti%2CG&author=Sanctis%2CV&author=Muni%2CR
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18398569's total income per month
- How profitable is http://scholar.google.com/scholar_lookup?&title=Toxicity%20from%20chemoradiotherapy%20in%20older%20patients%20with%20glioblastoma%20multiforme&journal=J%20Neurooncol&doi=10.1007%2Fs11060-008-9593-6&volume=89&issue=1&pages=97-103&publication_year=2008&author=Sijben%2CAE&author=McIntyre%2CJB&author=Rold%C3%A1n%2CGB?
- How much income is https://doi.org/10.1002%2Fcncr.24406 earning monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19514084
- How much income does http://scholar.google.com/scholar_lookup?&title=Temozolomide%20concomitant%20and%20adjuvant%20to%20radiotherapy%20in%20elderly%20patients%20with%20glioblastoma%3A%20correlation%20with%20MGMT%20promoter%20methylation%20status&journal=Cancer&doi=10.1002%2Fcncr.24406&volume=115&pages=3512-3518&publication_year=2009&author=Brandes%2CAA&author=Franceschi%2CE&author=Tosoni%2CA have?
- What's the total monthly financial gain of https://doi.org/10.1212%2FWNL.0b013e3181bf9907?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19884580?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Mgmt%20methylation%20is%20a%20prognostic%20biomarker%20in%20elderly%20patients%20with%20newly%20diagnosed%20glioblastoma&journal=Neurology&doi=10.1212%2FWNL.0b013e3181bf9907&volume=73&issue=18&pages=1509-1510&publication_year=2009&author=Gerstner%2CER&author=Yip%2CS&author=Wang%2CDL&author=Louis%2CDN&author=Iafrate%2CAJ&author=Batchelor%2CTT?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2358840
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Response%20criteria%20for%20phase%20II%20studies%20of%20supratentorial%20malignant%20glioma&journal=J%20Clin%20Oncol&volume=8&pages=1277-1280&publication_year=1990&author=MacDonald%2CDR&author=Cascino%2CTL&author=Schold%2CSC
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16944309?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Early%20necrosis%20following%20concurrent%20Temodar%20and%20radiotherapy%20in%20patients%20with%20glioblastoma&journal=J%20Neurooncol&doi=10.1007%2Fs11060-006-9241-y&volume=82&pages=81-83&publication_year=2007&author=Chamberlain%2CMC&author=Glantz%2CMJ&author=Chalmers%2CL&author=Horn%2CA&author=Sloan%2CAE make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10029064 make?
- See how much http://scholar.google.com/scholar_lookup?&title=Inactivation%20of%20the%20DNA%20repair%20gene%20O6-methylguanine-DNA%20methyltransferase%20by%20promoter%20hypermethylation%20is%20a%20common%20event%20in%20primary%20human%20neoplasia&journal=Cancer%20Res&volume=59&pages=793-797&publication_year=1999&author=Esteller%2CM&author=Hamilton%2CSR&author=Burger%2CPC&author=Baylin%2CSB&author=Herman%2CJG makes per month
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20radiotherapy%20with%20concomitant%20and%20adjuvant%20temozolomide%20versus%20radiotherapy%20alone%20on%20survival%20in%20glioblastoma%20in%20a%20randomised%20phase%20III%20study%3A%205-year%20analysis%20of%20the%20EORTC-NCIC%20trial&journal=Lancet%20Oncol&volume=10&pages=459-466&publication_year=2009 produce monthly?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16724687?
- http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20glioblastoma%20multiforme%20in%20elderly%20patients.%20Clinico-therapeutic%20remarks%20in%2022%20patients%20older%20than%2080%C2%A0years&journal=Tumori&volume=92&pages=98-103&publication_year=2006&author=Piccirilli%2CM&author=Bistazzoni%2CS&author=Gagliardi%2CFM's revenue stream
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9850030's revenue stream
- Financial intake of http://scholar.google.com/scholar_lookup?&title=DNA%20mismatch%20repair%20and%20O6-alkylguanine-DNA%20alkyltransferase%20analysis%20and%20response%20to%20Temodal%20in%20newly%20diagnosed%20malignant%20glioma&journal=J%20Clin%20Oncol&volume=16&pages=3851-3857&publication_year=1998&author=Friedman%2CHS&author=McLendon%2CRE&author=Kerby%2CT
- Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1007/s11060-010-0324-4?format=refman&flavour=references
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giuseppe%20Minniti?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giuseppe%20Minniti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Salvati
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Salvati%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Arcella?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Arcella%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F.%20Buttarelli?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F.%20Buttarelli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20D%E2%80%99Elia make?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20D%E2%80%99Elia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G.%20Lanzetta?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G.%20Lanzetta%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=V.%20Esposito
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22V.%20Esposito%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Scarpino have?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Scarpino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Maurizi%20Enrici is on a monthly basis
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Maurizi%20Enrici%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F.%20Giangaspero have monthly?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F.%20Giangaspero%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Profit of https://s100.copyright.com/AppDispatchServlet?title=Correlation%20between%20O6-methylguanine-DNA%20methyltransferase%20and%20survival%20in%20elderly%20patients%20with%20glioblastoma%20treated%20with%20radiotherapy%20plus%20concomitant%20and%20adjuvant%20temozolomide&author=Giuseppe%20Minniti%20et%20al&contentID=10.1007%2Fs11060-010-0324-4©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-594X&publicationDate=2010-08-05&publisherName=SpringerNature&orderBeanReset=true
- What's the financial gain of https://citation-needed.springer.com/v2/references/10.1007/s11060-010-0324-4?format=refman&flavour=citation?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral net monthly?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research pull in?
- How much income is https://www.springernature.com/gp/products earning monthly?
- How much revenue does https://www.springernature.com/gp/librarians produce monthly?
- https://www.springernature.com/gp/societies income
- Find out how much https://www.springernature.com/gp/partners earns monthly
- What's the income generated by https://www.springer.com/ each month?
- Find out how much https://www.nature.com/ earns monthly
- How much does https://www.biomedcentral.com/ pull in?
- How much does https://www.palgrave.com/ bring in each month?
- Earnings of https://www.apress.com/
- How much cash flow does https://www.springernature.com/gp/legal/ccpa have monthly?
- How much revenue does https://www.springernature.com/gp/info/accessibility generate?
- Revenue of https://support.springernature.com/en/support/home
- Learn about the earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- What is the earnings of https://www.springernature.com/?
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Prism.js
CDN Services {đŚ}
- Crossref